PRINT COMPANY INFORMATION
Market Information:
Last Trade:
53.60
Last Update Jun 19, 2013 at 05:05PM
Change
Open Price
53.6
Adjusted Open Price 53.0
Yesterday Close Price
53.0
Close Price
54.5
Day's Range
53.6 - 55.0
Volume
622100
Total Trade
762
Market Cap in BDT* 16145.87 (mn)
Basic Information:
Authorized Capital in BDT* (mn)
9100.0
Paid-up
Capital in BDT* (mn)
3046.0 52 Week's Range
47.3 - 69
Face Value
10.0 Market Lot 50
Total no. of Securities 304639050 Business Segment Pharmaceuticals & Chemicals
VIEW CLOSE PRICE GRAPH FOR
VIEW TOTAL TRADES GRAPH FOR
Last AGM Held: 30/06/2012
Bonus Issue 21% 2011, 20% 2010, 15% 2009, 20% 2008, 10% 2007, 10% 2006, 25% 2004,10% 2003, 15% 2002, 50% 97
Right Issue Merger with Bx Infusion 2005,1:1 ( at premium Tk.325 )1992,1:1 ( at premium Tk.1100 )1994
Year End
201112
Reserve & Surplus in BDT* (mn) 8812.26
Interim
Financial Performance: 2013
Particulars
Unaudited
/ Audited
Q1(3 Months)
Q2(6 Months)
Q3(9 Months)
Q4 (12 Months)
201303
Turn Over in BDT* (mn)
2263.01
n/a
n/a
n/a
Net Profit After Tax in BDT *(mn) (Continuing Operations)
282.93
n/a
n/a
n/a
Net
Profit After Tax in BDT *(mn)
0
n/a
n/a
n/a
Basic EPS in BDT*
0.930
n/a
n/a
n/a
Diluted EPS in BDT* (Based on continuing
operations)
0.810
n/a
n/a
n/a
Basic
EPS in BDT*
0.000
n/a
n/a
n/a
Diluted EPS in BDT* (Including Extra-ordinary Income)
0.000
n/a
n/a
n/a
Profit Status :
Basic
Diluted
Current Price Earning Ratio (P/E) 14.65
16.82
Current Price Earning Ratio (P/E)
* Note - Based on Annualized
EPS of 2013 (Q1)
Price Earning Ratio Based
on last Audited Financials:
Current Price Earning Ratio (P/E) 13.87
Current Price Earning Ratio (P/E)
* Note - Based on
audited EPS of 2011
Year Basic
EPS Basic
EPS (restated) Net Asset Value Per Share Restated
Net Asset Value Per Share Net Profit After Tax (mn)
Based on
Based on
Continuing operations
Including
Extra-Ordinary Income
Continuing operations
Including Extra-Ordinary
Income
Continuing operations
Including Extra-Ordinary
Income
2000
9.00
n/a
n/a
n/a
85.06
n/a
398.30
n/a
2001
9.08
n/a
n/a
n/a
94.14
n/a
401.78
n/a
2002
7.72
n/a
n/a
n/a
100.36
n/a
341.68
n/a
2003
4.41
n/a
n/a
n/a
91.25
n/a
224.64
n/a
2004
5.26
n/a
n/a
n/a
88.87
n/a
294.30
n/a
2005
6.36
n/a
n/a
n/a
61.01
n/a
489.26
n/a
2006
n/a
n/a
4.67 (wegt)
n/a
77.37
n/a
470.66
n/a
2007
3.08
n/a
2.80
n/a
73.56
65.51
353.07
n/a
2008
4.33
n/a
3.61
n/a
82.97
69.14
545.34
n/a
2009
4.13
n/a
3.59
n/a
72.02
62.63
624.74
n/a
2010
5.17
n/a
4.31
n/a
76.14
63.45
1051.65
n/a
2011
4.76
n/a
3.93
n/a
67.49
55.78
1198.53
n/a
2012
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
All figures in BDT (Bangladeshi Taka)
Financial Performance (Continue):
Year Year End P/E % Dividend % Dividend Yield
Based on
Continuing operations
Including
Extra-Ordinary Income
2000
5.42
n/a
20.00
4.10
2001
4.59
n/a
15.00
3.60
2002
13.39
n/a
5.00,15%B
8.10
2003
5.12
n/a
10.00,10%B
1.27
2004
16.30
n/a
5.00,25%B
0.58
2005
6.87
n/a
15.00
2.60
2006
11.50
n/a
5.00, 10%B
0.93
2007
19.12
n/a
5.00, 10%B
0.86
2008
46.45
n/a
10%, 20%B
0.60
2009
43.40
n/a
15%B
n/a
2010
31.35
n/a
20%B
-
2011
23.82
n/a
21%B
n/a
2012
n/a
n/a
n/a
n/a
Details of Financial Statement
Price Sensitive Information
Other Information of the Company:
Listing Year
1986
Market Category A
Electronic Share
Y
Share Percentage:
Sponsor/Director 11.61 Govt.0 Institute 11.57 Foreign 23.82 Public 53
Remark
1. As per letter dated 09.02.2010, the company has confirmed that 20,500,000 Preference Shares of Tk. 100.00 each have been converted into 16,169,191 Ordinary Shares.
2. As per letter dated 16.06.2010, the company has confirmed that 20,500,000 Preference Shares of Tk. 100.00 each have been converted into 15,121,956 Ordinary Shares.
3. TK 1,466,602,600 Revaluation Surplus has been added to Reserve and Surplus.
Address of the Company:
Address: 17, Dhanmondi R/A, Road # 02, Dhaka - 1209
Contact Phone: 8611891 - 5, 8618220 - 7, 9677701 - 5
Fax: 88 - 02 - 8613470, 8617647
E-mail:
info@bpl.net
Web Address:
http://www.beximco-pharma.com
dse@bol-online.com , Web: http://www.dsebd.org/
